Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Female Pelvic Med Reconstr Surg. 2011;17(1):30–35. doi: 10.1097/SPV.0b013e318205e263

Table 1.

Characteristics of the study population at baseline, by treatment group. Data presented as N (%) unless otherwise noted.


Variable
Combined
N=150
Behavioral
N=146
Pessary
N=149
P-value1

Mean age (SD) 49.5 (11.8) 49.6 (13.0) 50.2 (11.0) 0.86

Caucasian race 122 (81.3%) 132 (90.4%) 125 (84.5%) 0.26

Menstrual Status 0.91
 Pre-menopausal 68 (45.3%) 71 (48.6%) 75 (50.3%)
 Post-menopausal 66 (44.0%) 62 (42.5%) 60 (40.3%)
 Not sure 16 (10.7%) 13 (8.9%) 14 (9.4%)

Current Estrogen Use 16 (10.7%) 24 (16.4%) 27 (18.1%) 0.17

Body Mass Index (SD) 29.84 (7.54) 29.01 (6.89) 29.50 (6.05) 0.54

Incontinence Type2
 Stress Only 70 (46.7%) 65 (44.5%) 69 (46.3%) 0.92
 Mixed 80 (53.3%) 81 (55.5%) 80 (53.7%)

Incontinence Frequency2 0.98
 ≥14 episodes/week 67 (44.7%) 67 (45.9%) 68 (45.6%)
 <14 episodes/week 83 (55.3%) 79 (54.1%) 81 (54.4%)
1

ANOVA, controlling for stratification based on baseline incontinence episodes and incontinence type.

2

Incontinence type and frequency based on 7-day bladder diary: stress (no urge leaks recorded) or mixed (one or more urge leaks recorded).